Status:
UNKNOWN
Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial
Lead Sponsor:
Mespere Lifesciences Inc.
Collaborating Sponsors:
Wayne State University
Conditions:
Severe Sepsis
Acute Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the impact that the Venus 1000 non-invasive CVP system has on the management of emergency department (ED) patients with fluid sensitive conditions.
Detailed Description
The ability to non-invasively, accurately, and continuously measure CVP to assess the preload status of ED patients could lead to its inclusion into existing protocols (similar to EGDT), or the develo...
Eligibility Criteria
Inclusion
- Age 18 years old or greater
- English speaking
- Clinical diagnosis of: 1) Severe Sepsis, or 2) Acute Heart Failure
Exclusion
- Traumatic injuries
- Active bleeding
- Pregnancy
- Prisoners
- Central venous catheter placement in the internal jugular or subclavian veins
- Bilateral external jugular vein catheterizations
- Concurrent enrollment into an interventional clinical trial that may affect subject treatment
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT02258984
Start Date
October 1 2014
End Date
December 1 2015
Last Update
September 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Detroit Receiving Hospital
Detroit, Michigan, United States